Table 3.

Kidney outcomes by assignment to placebo or RBX long-term studies of diabetic eye diseasea

CharacteristicPlaceboRBX 32 mg/dTotalP
Doubling of serum creatinine6.1% (35/577)5.9% (34/580)6.0% (69/1157)0.88
Progression to advanced CKD4.3% (25/577)3.8% (22/580)4.1% (47/1157)0.64
Death4.7% (27/577)3.6% (21/580)4.1% (48/1157)0.37
At least one kidney outcome11.8% (68/577)10.9% (63/580)11.3% (131/1157)0.62
  • a CKD, chronic kidney disease.